ARCHIVES

Transplant Is Viable Option For HIV+ Patients, Study Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 2 | February 25, 2005

Download PDF Visit The Full Archive

Related Articles

Politics, Short Tempers, Grievances Dominate NIH Panel On Unconventional Medical Practices

September 25, 1992

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

In Brief: GM Awards Recognize Levine, Levy, Roeder, Tjian; U.S. Science, Tech Medals Awarded

May 14, 1999

Funding Opportunity: PanCAN Offering $4.1 Million in Research Grants

September 12, 2014

FDA Relies on Importation, Fast Approval, and Early Reporting to Combat Drug Shortages

February 24, 2012

Five Center Core Grants Renewed

February 2, 1979